BRAF and familial pancreatic carcinoma: In a whole exome sequencing study by Witkiewicz et al. [82], it was shown that mutations in BRAF V600 were present in 3% of mainly early stage pancreatic cancers (different histological subtypes) and were mutually exclusive with KRAS mutations.